Tesamorelin 8mg

What is Tesamorelin (8 mg)?

Tesamorelin (8 mg) is a synthetic peptide analog of human growth hormone–releasing hormone (GHRH), primarily used in research to study the biological processes involved in GHRH signaling. This peptide plays an essential role in endocrine studies, particularly for exploring the mechanisms of growth hormone release and its physiological effects within experimental models.

Product Specifications

• CAS Number: 218949-48-5
• Peptide Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
• Category: Peptides
• Subcategory: Muscle Growth & Performance Peptides
• Molecular Weight: 5136 g/mol
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Synonyms: TH9507
• Purity: ≥99%
• Packaging Format: 8 mg
• Storage Conditions: Store at -20°C, avoid light exposure
• Designation: For Laboratory Research Use Only

Key Characteristics of Tesamorelin (8 mg)

• A well-defined peptide sequence that ensures consistency in experimental setups.
• Primarily used for studies on GHRH signaling and the evaluation of downstream biomarkers in endocrine models.
• High purity (≥99%) to minimize variability and improve reliability in research workflows.
• The 8 mg format is suitable for method development, repeated assays, and multi-stage research protocols.
• Requires low-temperature, light-protected storage to support research applications.

How Tesamorelin (8 mg) Supports Research

Tesamorelin is a vital tool for investigating GHRH receptor signaling and its downstream biological responses in experimental systems. Researchers use this peptide to explore receptor engagement, signaling patterns, and the effects on metabolic functions in controlled environments. Tesamorelin’s design facilitates the investigation of metabolic signaling pathways and endocrine signaling dynamics in model systems.

Research Applications & Usage Information

Tesamorelin (8 mg) is commonly used in laboratory research for:

• Endocrine signaling studies examining GHRH-related pathways and downstream marker shifts.
• Profiling receptor interactions and comparing signaling responses across different peptide tools.
• Protein signaling and gene-expression research, focusing on growth hormone-related markers.
• Assay development and validation, ensuring repeatability and consistency in research.
• Analytical verification, confirming peptide identity and comparability across experimental conditions.

Note: This material is intended for laboratory research only. Research methods and models may vary by institution and protocol.

Handling and Storage Recommendations

• Store at 2–8°C (≤–20°C for long-term storage). Protect from light (keep the vial in its original packaging or use a light-blocking container).
• Minimize freeze-thaw cycles to support research applications.
• Keep the vial tightly sealed and use proper laboratory techniques to prevent contamination.
• Follow your facility’s chemical hygiene plan, labeling rules, and disposal procedures.

Research Use Only Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

1. Tesamorelin. PubChem Compound Summary for CID 16137828. Bethesda, MD: National Center for Biotechnology Information; 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin
2. US Food and Drug Administration. Pharmacology Review(s). NDA/BLA 022505Orig1s000PharmR. Silver Spring, MD: US FDA; 2010. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000PharmR.pdf
3. US Food and Drug Administration. Tesamorelin acetate. GSRS/GINAS substance record; UNII LGW5H38VE3. Silver Spring, MD: US FDA. https://precision.fda.gov/ginas/app/ui/substances/0815de8e-8238-401d-a2f6-f88577ae1947
4. Izdebski J, Pinski J, Horvath JE, Halmos G, Groot K, Schally AV. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 1995;92(11):4872-4876. doi:10.1073/pnas.92.11.4872